CJC-1295 + Ipamorelin is a synergistic peptide combination designed for the investigation of growth hormone (GH) secretion. CJC-1295 (No DAC) is a 29-amino acid tetrasubstituted peptide analog of Growth Hormone Releasing Hormone (GHRH). Ipamorelin is a selective pentapeptide agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R). When combined, these compounds operate via two distinct pathways to stimulate the pituitary gland: CJC-1295 mimics the endogenous signal to initiate GH release, while Ipamorelin amplifies the pulse and suppresses somatostatin. Research applications include investigations into muscle tissue hypertrophy, lipolysis, and cellular repair mechanisms.
All products currently listed on this site are for research purposes only.